{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:54:07Z","timestamp":1791107647521,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:00:00Z","timestamp":1273104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:00:00Z","timestamp":1273104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/leu.2010.67","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T10:03:33Z","timestamp":1273140213000},"page":"1105-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["BCR\u2013ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia"],"prefix":"10.1038","volume":"24","author":[{"given":"B A","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,6]]},"reference":[{"key":"BFleu201067_CR1","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFleu201067_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031\u20131037.","journal-title":"N Engl J Med"},{"key":"BFleu201067_CR3","first-page":"20","volume":"25","author":"R Bernstein","year":"1988","unstructured":"Bernstein R . Cytogenetics of chronic myelogenous leukemia. Semin Hematol 1988; 25: 20\u201334.","journal-title":"Semin Hematol"},{"key":"BFleu201067_CR4","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V80.7.1788.1788","volume":"80","author":"P Laneuville","year":"1992","unstructured":"Laneuville P, Sun G, Timm M, Vekemans M . Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr\/abl. Blood 1992; 80: 1788\u20131797.","journal-title":"Blood"},{"key":"BFleu201067_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/sj.leu.2401855","volume":"14","author":"HF Salloukh","year":"2000","unstructured":"Salloukh HF, Laneuville P . Increase in mutant frequencies in mice expressing the BCR-ABL activated tyrosine kinase. Leukemia 2000; 14: 1401\u20131404.","journal-title":"Leukemia"},{"key":"BFleu201067_CR6","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1182\/blood-2002-10-3011","volume":"101","author":"E Deutsch","year":"2003","unstructured":"Deutsch E, Jarrousse S, Buet D, Dugray A, Bonnet ML, Vozenin-Brotons MC et al. Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells. Blood 2003; 101: 4583\u20134588.","journal-title":"Blood"},{"key":"BFleu201067_CR7","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/leu.2008.78","volume":"22","author":"M Koptyra","year":"2008","unstructured":"Koptyra M, Cramer K, Slupianek A, Richardson C, Skorski T . BCR\/\/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia 2008; 22: 1969\u20131972.","journal-title":"Leukemia"},{"key":"BFleu201067_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/leu.2008.308","volume":"23","author":"J Dierov","year":"2009","unstructured":"Dierov J, Sanchez PV, Burke BA, Padilla-Nash H, Putt ME, Ried T et al. BCR\/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold. Leukemia 2009; 23: 279\u2013286.","journal-title":"Leukemia"},{"key":"BFleu201067_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/03093640701859089","volume":"49","author":"T Skorski","year":"2008","unstructured":"Skorski T . BCR\/ABL, DNA damage and DNA repair: implications for new treatment concepts. Leuk Lymphoma 2008; 49: 610\u2013614.","journal-title":"Leuk Lymphoma"},{"key":"BFleu201067_CR10","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","volume":"105","author":"JH Kim","year":"2005","unstructured":"Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D et al. Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 2005; 105: 1717\u20131723.","journal-title":"Blood"},{"key":"BFleu201067_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","volume":"108","author":"M Koptyra","year":"2006","unstructured":"Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M et al. BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 2006; 108: 319\u2013327.","journal-title":"Blood"},{"key":"BFleu201067_CR12","doi-asserted-by":"publisher","first-page":"24273","DOI":"10.1074\/jbc.M002094200","volume":"275","author":"M Sattler","year":"2000","unstructured":"Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB, Winkler T et al. The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 2000; 275: 24273\u201324278.","journal-title":"J Biol Chem"},{"key":"BFleu201067_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2009.07.030","volume":"16","author":"L Klemm","year":"2009","unstructured":"Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009; 16: 232\u2013245.","journal-title":"Cancer Cell"},{"key":"BFleu201067_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev.biochem.69.1.497","volume":"69","author":"TA Kunkel","year":"2000","unstructured":"Kunkel TA, Bebenek K . DNA replication fidelity. Annu Rev Biochem 2000; 69: 497\u2013529.","journal-title":"Annu Rev Biochem"},{"key":"BFleu201067_CR15","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1182\/blood-2005-03-1036","volume":"106","author":"SG Willis","year":"2005","unstructured":"Willis SG, Lange T, Demehri S, Otto S, Crossman L, Niederwieser D et al. High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy. Blood 2005; 106: 2128\u20132137.","journal-title":"Blood"},{"key":"BFleu201067_CR16","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876\u2013880.","journal-title":"Science"},{"key":"BFleu201067_CR17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","volume":"361","author":"ER Mardis","year":"2009","unstructured":"Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058\u20131066.","journal-title":"N Engl J Med"},{"key":"BFleu201067_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature07485","volume":"456","author":"TJ Ley","year":"2008","unstructured":"Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008; 456: 66\u201372.","journal-title":"Nature"},{"key":"BFleu201067_CR19","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-07-6858","volume":"68","author":"T Stoklosa","year":"2008","unstructured":"Stoklosa T, Poplawski T, Koptyra M, Nieborowska-Skorska M, Basak G, Slupianek A et al. BCR\/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations. Cancer Res 2008; 68: 2576\u20132580.","journal-title":"Cancer Res"},{"key":"BFleu201067_CR20","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/blood-2002-10-3207","volume":"102","author":"Y Canitrot","year":"2003","unstructured":"Canitrot Y, Falinski R, Louat T, Laurent G, Cazaux C, Hoffmann JS et al. p210 BCR\/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation. Blood 2003; 102: 2632\u20132637.","journal-title":"Blood"},{"key":"BFleu201067_CR21","first-page":"3722","volume":"9","author":"E Laurent","year":"2003","unstructured":"Laurent E, Mitchell DL, Estrov Z, Lowery M, Tucker SL, Talpaz M et al. Impact of p210(Bcr-Abl) on ultraviolet C wavelength-induced DNA damage and repair. Clin Cancer Res 2003; 9: 3722\u20133730.","journal-title":"Clin Cancer Res"},{"key":"BFleu201067_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/bbrc.1999.0822","volume":"260","author":"Y Maru","year":"1999","unstructured":"Maru Y, Kobayashi T, Tanaka K, Shibuya M . BCR binds to the xeroderma pigmentosum group B protein. Biochem Biophys Res Commun 1999; 260: 309\u2013312.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu201067_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1073\/pnas.96.1.203","volume":"96","author":"N Takeda","year":"1999","unstructured":"Takeda N, Shibuya M, Maru Y . The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein. Proc Natl Acad Sci USA 1999; 96: 203\u2013207.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201067_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0027-5107(01)00229-9","volume":"483","author":"Y Maru","year":"2001","unstructured":"Maru Y, Bergmann E, Coin F, Egly JM, Shibuya M . TFIIH functions are altered by the P210BCR-ABL oncoprotein produced on the Philadelphia chromosome. Mutat Res 2001; 483: 83\u201388.","journal-title":"Mutat Res"},{"key":"BFleu201067_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1535-6108(04)00056-X","volume":"5","author":"J Dierov","year":"2004","unstructured":"Dierov J, Dierova R, Carroll M . BCR\/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint. Cancer Cell 2004; 5: 275\u2013285.","journal-title":"Cancer Cell"},{"key":"BFleu201067_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/84683","volume":"7","author":"P Vigneri","year":"2001","unstructured":"Vigneri P, Wang JY . Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med 2001; 7: 228\u2013234.","journal-title":"Nat Med"},{"key":"BFleu201067_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4161\/cc.5.9.2722","volume":"5","author":"M Nieborowska-Skorska","year":"2006","unstructured":"Nieborowska-Skorska M, Stoklosa T, Datta M, Czechowska A, Rink L, Slupianek A et al. ATR-Chk1 axis protects BCR\/ABL leukemia cells from the lethal effect of DNA double-strand breaks. Cell Cycle 2006; 5: 994\u20131000.","journal-title":"Cell Cycle"},{"key":"BFleu201067_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.mrgentox.2008.06.002","volume":"654","author":"T Sliwinski","year":"2008","unstructured":"Sliwinski T, Czechowska A, Szemraj J, Morawiec Z, Skorski T, Blasiak J . STI571 reduces NER activity in BCR\/ABL-expressing cells. Mutat Res 2008; 654: 162\u2013167.","journal-title":"Mutat Res"},{"key":"BFleu201067_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.dnarep.2005.10.005","volume":"5","author":"A Slupianek","year":"2006","unstructured":"Slupianek A, Nowicki MO, Koptyra M, Skorski T . BCR\/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair 2006; 5: 243\u2013250.","journal-title":"DNA Repair"},{"key":"BFleu201067_CR30","first-page":"2791","volume":"62","author":"TJ Gaymes","year":"2002","unstructured":"Gaymes TJ, Mufti GJ, Rassool FV . Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70\/86 heterodimer. Cancer Res 2002; 62: 2791\u20132797.","journal-title":"Cancer Res"},{"key":"BFleu201067_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1515\/znc-2005-5-619","volume":"60","author":"E Pastwa","year":"2005","unstructured":"Pastwa E, Poplawski T, Czechowska A, Malinowski M, Blasiak J . Non-homologous DNA end joining repair in normal and leukemic cells depends on the substrate ends. Z Naturforsch (C) 2005; 60: 493\u2013500.","journal-title":"Z Naturforsch (C)"},{"key":"BFleu201067_CR32","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1182\/blood.V97.7.2084","volume":"97","author":"E Deutsch","year":"2001","unstructured":"Deutsch E, Dugray A, AbdulKarim B, Marangoni E, Maggiorella L, Vaganay S et al. BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood 2001; 97: 2084\u20132090.","journal-title":"Blood"},{"key":"BFleu201067_CR33","first-page":"1798","volume":"63","author":"N Brady","year":"2003","unstructured":"Brady N, Gaymes TJ, Cheung M, Mufti GJ, Rassool FV . Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins. Cancer Res 2003; 63: 1798\u20131805.","journal-title":"Cancer Res"},{"key":"BFleu201067_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature06168","volume":"449","author":"B Corneo","year":"2007","unstructured":"Corneo B, Wendland RL, Deriano L, Cui X, Klein IA, Wong SY et al. Rag mutations reveal robust alternative end joining. Nature 2007; 449: 483\u2013486.","journal-title":"Nature"},{"key":"BFleu201067_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1432-1327.1998.2580387.x","volume":"258","author":"B Gottlich","year":"1998","unstructured":"Gottlich B, Reichenberger S, Feldmann E, Pfeiffer P . Rejoining of DNA double-strand breaks in vitro by single-strand annealing. Eur J Biochem\/FEBS 1998; 258: 387\u2013395.","journal-title":"Eur J Biochem\/FEBS"},{"key":"BFleu201067_CR36","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1158\/0008-5472.CAN-04-3055","volume":"65","author":"H Wang","year":"2005","unstructured":"Wang H, Rosidi B, Perrault R, Wang M, Zhang L, Windhofer F et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 2005; 65: 4020\u20134030.","journal-title":"Cancer Res"},{"key":"BFleu201067_CR37","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1093\/nar\/gkl840","volume":"34","author":"M Wang","year":"2006","unstructured":"Wang M, Wu W, Rosidi B, Zhang L, Wang H, Iliakis G . PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 2006; 34: 6170\u20136182.","journal-title":"Nucleic Acids Res"},{"key":"BFleu201067_CR38","first-page":"547","volume":"62","author":"J Oshima","year":"2002","unstructured":"Oshima J, Huang S, Pae C, Campisi J, Schiestl RH . Lack of WRN results in extensive deletion at nonhomologous joining ends. Cancer Res 2002; 62: 547\u2013551.","journal-title":"Cancer Res"},{"key":"BFleu201067_CR39","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood-2007-07-104257","volume":"112","author":"A Sallmyr","year":"2008","unstructured":"Sallmyr A, Tomkinson AE, Rassool FV . Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 2008; 112: 1413\u20131423.","journal-title":"Blood"},{"key":"BFleu201067_CR40","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1182\/blood-2004-05-1941","volume":"104","author":"MO Nowicki","year":"2004","unstructured":"Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E et al. BCR\/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004; 104: 3746\u20133753.","journal-title":"Blood"},{"key":"BFleu201067_CR41","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1128\/MCB.22.12.4189-4201.2002","volume":"22","author":"A Slupianek","year":"2002","unstructured":"Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J et al. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)\/M phase, and protection from apoptosis. Mol Cell Biol 2002; 22: 4189\u20134201.","journal-title":"Mol Cell Biol"},{"key":"BFleu201067_CR42","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.1074\/jbc.274.18.12748","volume":"274","author":"G Chen","year":"1999","unstructured":"Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B et al. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem 1999; 274: 12748\u201312752.","journal-title":"J Biol Chem"},{"key":"BFleu201067_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/34937","volume":"391","author":"FE Benson","year":"1998","unstructured":"Benson FE, Baumann P, West SC . Synergistic actions of Rad51 and Rad52 in recombination and DNA repair. Nature 1998; 391: 401\u2013404.","journal-title":"Nature"},{"key":"BFleu201067_CR44","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1097-2765(01)00357-4","volume":"8","author":"A Slupianek","year":"2001","unstructured":"Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO et al. BCR\/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001; 8: 795\u2013806.","journal-title":"Mol Cell"},{"key":"BFleu201067_CR45","first-page":"2766","volume":"62","author":"G Langland","year":"2002","unstructured":"Langland G, Elliott J, Li Y, Creaney J, Dixon K, Groden J . The BLM helicase is necessary for normal DNA double-strand break repair. Cancer Res 2002; 62: 2766\u20132770.","journal-title":"Cancer Res"},{"key":"BFleu201067_CR46","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1038\/sj.onc.1208545","volume":"24","author":"A Slupianek","year":"2005","unstructured":"Slupianek A, Gurdek E, Koptyra M, Nowicki MO, Siddiqui KM, Groden J et al. BLM helicase is activated in BCR\/ABL leukemia cells to modulate responses to cisplatin. Oncogene 2005; 24: 3914\u20133922.","journal-title":"Oncogene"},{"key":"BFleu201067_CR47","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1158\/0008-5472.CAN-08-1101","volume":"68","author":"K Cramer","year":"2008","unstructured":"Cramer K, Nieborowska-Skorska M, Koptyra M, Slupianek A, Penserga ET, Eaves CJ et al. BCR\/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair. Cancer Res 2008; 68: 6884\u20136888.","journal-title":"Cancer Res"},{"key":"BFleu201067_CR48","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1182\/blood-2008-07-172148","volume":"114","author":"MS Fernandes","year":"2009","unstructured":"Fernandes MS, Reddy MM, Gonneville JR, DeRoo SC, Podar K, Griffin JD et al. BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair. Blood 2009; 114: 1813\u20131819.","journal-title":"Blood"},{"key":"BFleu201067_CR49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/387516a0","volume":"387","author":"R Baskaran","year":"1997","unstructured":"Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 1997; 387: 516\u2013519.","journal-title":"Nature"},{"key":"BFleu201067_CR50","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/sj.leu.2402223","volume":"15","author":"JV Melo","year":"2001","unstructured":"Melo JV, Kumberova A, van Dijk AG, Goldman JM, Yuille MR . Investigation on the role of the ATM gene in chronic myeloid leukaemia. Leukemia 2001; 15: 1448\u20131450.","journal-title":"Leukemia"},{"key":"BFleu201067_CR51","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1091\/mbc.e03-12-0900","volume":"15","author":"A Tritarelli","year":"2004","unstructured":"Tritarelli A, Oricchio E, Ciciarello M, Mangiacasale R, Palena A, Lavia P et al. p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation. Mol Biol Cell 2004; 15: 3751\u20133757.","journal-title":"Mol Biol Cell"},{"key":"BFleu201067_CR52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1126\/science.292.5516.426","volume":"292","author":"J Marx","year":"2001","unstructured":"Marx J . Cell biology. Do centrosome abnormalities lead to cancer? Science (New York) 2001; 292: 426\u2013429.","journal-title":"Science (New York)"},{"key":"BFleu201067_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/35048096","volume":"2","author":"EA Nigg","year":"2001","unstructured":"Nigg EA . Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev 2001; 2: 21\u201332.","journal-title":"Nat Rev"},{"key":"BFleu201067_CR54","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/sj.leu.2404834","volume":"21","author":"M Giehl","year":"2007","unstructured":"Giehl M, Fabarius A, Frank O, Erben P, Zheng C, Hafner M et al. Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells. Leukemia 2007; 21: 1971\u20131976.","journal-title":"Leukemia"},{"key":"BFleu201067_CR55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/sj.leu.2403779","volume":"19","author":"M Giehl","year":"2005","unstructured":"Giehl M, Fabarius A, Frank O, Hochhaus A, Hafner M, Hehlmann R et al. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia 2005; 19: 1192\u20131197.","journal-title":"Leukemia"},{"key":"BFleu201067_CR56","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.4049\/jimmunol.145.6.1859","volume":"145","author":"SJ Martin","year":"1990","unstructured":"Martin SJ, Lennon SV, Bonham AM, Cotter TG . Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990; 145: 1859\u20131867.","journal-title":"J Immunol"},{"key":"BFleu201067_CR57","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","volume":"83","author":"A McGahon","year":"1994","unstructured":"McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG . BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994; 83: 1179\u20131187.","journal-title":"Blood"},{"key":"BFleu201067_CR58","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/sj.onc.1201664","volume":"16","author":"GP Amarante-Mendes","year":"1998","unstructured":"Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DE, Witte ON, Green DR . Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL. Oncogene 1998; 16: 1383\u20131390.","journal-title":"Oncogene"},{"key":"BFleu201067_CR59","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/sj.leu.2402309","volume":"15","author":"K Keeshan","year":"2001","unstructured":"Keeshan K, Mills KI, Cotter TG, McKenna SL . Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype. Leukemia 2001; 15: 1823\u20131833.","journal-title":"Leukemia"},{"key":"BFleu201067_CR60","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/sj.leu.2402576","volume":"16","author":"K Keeshan","year":"2002","unstructured":"Keeshan K, Cotter TG, McKenna SL . High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion. Leukemia 2002; 16: 1725\u20131734.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201067","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T02:03:25Z","timestamp":1685585005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFleu201067"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.67","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,6]]},"assertion":[{"value":"2 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}